Literature DB >> 24233263

Terminal deletion of 11q with significant late-onset combined immune deficiency.

Mikko Seppänen, Hannele Koillinen, Satu Mustjoki, Mölkänen Tomi, Kathleen E Sullivan.   

Abstract

PURPOSE: We report a 45-year old female adult patient with terminal deletion of chromosome 11q resulting in clinical phenotype of late-onset combined immunodeficiency.
METHODS: We describe the clinical phenotype and discuss the similarities between our patient and those with chromosome 22q11.2 deletion syndrome. Immunological evaluation included immunoglobulin levels, vaccine responses, number and function of T, NK and B cell subsets and comparative genomic hybridization test of blood and fibroblasts.
RESULTS: The patient suffered from recurrent pneumococcal pneumonia and genital and cutaneous condylomas. She had a history of learning difficulties, dysmorphic features, autoimmune thyroiditis, chronic thrombocytopenia and severe asthma. We found Paris-Trousseau type thrombocytopenia, B-, T- and NK-lymphopenia, T cell oligoclonality and IgG hypogammaglobulinemia with inability to respond to pneumococcal polysaccharide, tetanus and diphtheria vaccines. A terminal deletion of chromosome 11q compatible with partial Jacobsen syndrome was found.
CONCLUSIONS: This confirms Jacobsen syndrome as a chromosome deletion syndrome able to cause combined immunodeficiency.

Entities:  

Mesh:

Year:  2014        PMID: 24233263     DOI: 10.1007/s10875-013-9966-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  16 in total

1.  Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011).

Authors:  James W Verbsky; Mei W Baker; William J Grossman; Mary Hintermeyer; Trivikram Dasu; Benedetta Bonacci; Sreelatha Reddy; David Margolis; James Casper; Miranda Gries; Ken Desantes; Gary L Hoffman; Charles D Brokopp; Christine M Seroogy; John M Routes
Journal:  J Clin Immunol       Date:  2011-11-10       Impact factor: 8.317

2.  Induction of sustained deep molecular response in a patient with chronic-phase T315I-mutated chronic myeloid leukemia with interferon-α monotherapy.

Authors:  Mette Ilander; Perttu Koskenvesa; Sari Hernesniemi; Thomas Lion; Kimmo Porkka; Satu Mustjoki
Journal:  Leuk Lymphoma       Date:  2013-07-25

3.  Ets1 is required for proper migration and differentiation of the cardiac neural crest.

Authors:  Zhiguang Gao; Gene H Kim; Alexander C Mackinnon; Alleda E Flagg; Brett Bassett; Judy U Earley; Eric C Svensson
Journal:  Development       Date:  2010-03-31       Impact factor: 6.868

Review 4.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

5.  Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy.

Authors:  Peter Rohon; Kimmo Porkka; Satu Mustjoki
Journal:  Eur J Haematol       Date:  2010-11       Impact factor: 2.997

Review 6.  Review of Ets1 structure, function, and roles in immunity.

Authors:  Lee Ann Garrett-Sinha
Journal:  Cell Mol Life Sci       Date:  2013-01-05       Impact factor: 9.261

7.  The 11q terminal deletion disorder: a prospective study of 110 cases.

Authors:  Paul D Grossfeld; Teresa Mattina; Zona Lai; Remi Favier; Ken Lyons Jones; Finbarr Cotter; Christopher Jones
Journal:  Am J Med Genet A       Date:  2004-08-15       Impact factor: 2.802

8.  Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins.

Authors:  Birgit Simell; Mika Lahdenkari; Antti Reunanen; Helena Käyhty; Merja Väkeväinen
Journal:  Clin Vaccine Immunol       Date:  2008-07-02

9.  Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5 Mb deletion del(11)(q24.3).

Authors:  Joanna Bernaciak; Krzysztof Szczałuba; Katarzyna Derwińska; Barbara Wiśniowiecka-Kowalnik; Ewa Bocian; Maria Małgorzata Sasiadek; Izabela Makowska; Paweł Stankiewicz; Robert Smigiel
Journal:  Am J Med Genet A       Date:  2008-10-01       Impact factor: 2.802

10.  Clinical and molecular characterization of patients with distal 11q deletions.

Authors:  L A Penny; M Dell'Aquila; M C Jones; J Bergoffen; C Cunniff; J P Fryns; E Grace; J M Graham; B Kousseff; T Mattina
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

View more
  9 in total

Review 1.  Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia.

Authors:  Soma Jyonouchi; Artemio M Jongco; Jennifer Puck; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2017-03-28       Impact factor: 8.317

2.  Immunological Evaluation of Patients Affected with Jacobsen Syndrome Reveals Profound Not Age-Related Lymphocyte Alterations.

Authors:  Manuela Baronio; Francesco Saettini; Luisa Gazzurelli; Daniele Moratto; Vassilios Lougaris; Stefano Rossi; Antonio Marzollo; Silvia Ricci; Daniele Zama; Boaz Palterer; Canessa Clementina; Lodi Lorenzo; Marco Chiarini; Alessandra Sottini; Luisa Imberti; Chiara Gorio; Linda Rossini; Raffaele Badolato; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2021-11-20       Impact factor: 8.317

3.  Jacobsen Syndrome: Surgical Complications due to Unsuspected Diagnosis, the Importance of Molecular Studies in Patients with Craniosynostosis.

Authors:  Etzalli P Linares Chávez; Jaime Toral López; Juan M Valdés Miranda; Luz M González Huerta; Adrian Perez Cabrera; María Del Refugio Rivera Vega; Olga M Messina Baas; Sergio A Cuevas-Covarrubias
Journal:  Mol Syndromol       Date:  2015-12-18

4.  Primary immunodeficiency associated with chromosomal aberration - an ESID survey.

Authors:  Ellen Schatorjé; Michiel van der Flier; Mikko Seppänen; Michael Browning; Megan Morsheimer; Stefanie Henriet; João Farela Neves; Donald Cuong Vinh; Laia Alsina; Anete Grumach; Pere Soler-Palacin; Thomas Boyce; Fatih Celmeli; Ekaterini Goudouris; Grant Hayman; Richard Herriot; Elisabeth Förster-Waldl; Markus Seidel; Annet Simons; Esther de Vries
Journal:  Orphanet J Rare Dis       Date:  2016-08-02       Impact factor: 4.123

5.  Unexpectedly High Prevalence of Common Variable Immunodeficiency in Finland.

Authors:  Jannica S Selenius; Timi Martelius; Sampsa Pikkarainen; Sanna Siitonen; Eero Mattila; Risto Pietikäinen; Pekka Suomalainen; Arja H Aalto; Janna Saarela; Elisabet Einarsdottir; Asko Järvinen; Martti Färkkilä; Juha Kere; Mikko Seppänen
Journal:  Front Immunol       Date:  2017-09-28       Impact factor: 7.561

6.  Do microdeletions lead to immune deficiency?

Authors:  Sait Karaman; Filiz Hazan; Semiha Bahçeci Erdem; Nesrin Gülez; Ferah Genel
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085

7.  Jacobsen syndrome and neonatal bleeding: report on two unrelated patients.

Authors:  Gregorio Serra; Luigi Memo; Vincenzo Antona; Giovanni Corsello; Valentina Favero; Paola Lago; Mario Giuffrè
Journal:  Ital J Pediatr       Date:  2021-07-01       Impact factor: 2.638

8.  The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency.

Authors:  Virgil A S H Dalm; Gertjan J A Driessen; Barbara H Barendregt; Petrus M van Hagen; Mirjam van der Burg
Journal:  J Clin Immunol       Date:  2015-11-14       Impact factor: 8.317

Review 9.  Ultrasonographic findings and prenatal diagnosis of Jacobsen syndrome: A case report and review of the literature.

Authors:  Shuang Chen; Ruixue Wang; Xinyue Zhang; Leilei Li; Yuting Jiang; Ruizhi Liu; Hongguo Zhang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.